Autopsy report · NCT01189071

Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain

“Co-Investigator left institution. No data analysis occurred.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year after it had already started.
• Ran for about 1 year 11 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 5 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Missouri-Columbia

Sponsor type

University, hospital or other

Conditions

Overactive Bladder; Renal Colic; Pain, Postoperative

Interventions

Darifenacin

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
  “The study did not start as a key co-investigator left the institution.” (77% match in meaning)
• Continuous Femoral and Tibial Nerve Blocks in TKA Patients
  “Principal Investigator left institution--no subjects completed the study” (72% match in meaning)
• Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD
  “Principal investigator left the institution and study was never funded” (70% match in meaning)
• Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
  “Investigator departing institution and enrollment not met.” (69% match in meaning)
• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.